Dr. Gong is currently an Assistant Professor in the Cleveland Clinic Lerner College of Medicine, and Assistant Staff in Department of Cancer Biology of Cleveland Clinic. He received his Ph.D. from Giessen University at Germany. Dr. Gong pursued postdoctoral training in the laboratory of Dr. Junjie Chen at Yale University and MD Anderson Cancer Center, where he studied the DNA damage signaling pathway and DNA replication. Dr. Gong’s current research interests focus on synthetic lethality and synthetic viability: DNA repair pathway choice in ovarian cancer treatment. In addition to the Ovarian Cancer Research Fund Liz Tilberis Early Career Award, Dr. Gong’s work is also supported by NCI RO1 grant.